rs1557115532
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PM2PP3_ModeratePP5_Very_Strong
The NM_014009.4(FOXP3):c.1222G>A(p.Val408Met) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_014009.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 22
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 22
ClinVar
Submissions by phenotype
Insulin-dependent diabetes mellitus secretory diarrhea syndrome Pathogenic:3
This sequence change replaces valine, which is neutral and non-polar, with methionine, which is neutral and non-polar, at codon 408 of the FOXP3 protein (p.Val408Met). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with clinical features of IPEX syndrome, congenital enteropathy, and/or neonatal diabetes (PMID: 18931102, 30443250, 30894704, 32279225, 33833438, 34216291). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 435255). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt FOXP3 protein function with a positive predictive value of 80%. For these reasons, this variant has been classified as Pathogenic. -
Variant summary: FOXP3 c.1222G>A (p.Val408Met) results in a conservative amino acid change located in the Fork head domain of the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 182058 control chromosomes. c.1222G>A has been reported in the literature in individuals affected with Insulin-Dependent Diabetes Mellitus Secretory Diarrhea Syndrome. These data indicate that the variant is likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Two clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. One laboratory classified the variant as likely pathogenic, and one laboratory classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as likely pathogenic. -
- -
FOXP3-related disorder Pathogenic:1
The FOXP3 c.1222G>A variant is predicted to result in the amino acid substitution p.Val408Met. This variant was reported in individuals with neonatal diabetes and/or IPEX syndrome (Immunodysregulation, Polyendocrinopathy, Enteropathy, X-linked) (Rubio-Cabezas et al. 2009. PubMed ID: 18931102; Gambineri et al. 2018. PubMed ID: 30443250; Supplementary Table 1, Ye et al. 2019. PubMed ID: 30894704; Cao et al. 2020. PubMed ID: 32279225; Zemmour et al. 2021. PubMed ID: 33833438). This variant has not been reported in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. This variant is interpreted as likely pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at